Trial intelligence / Profile preview

Perindopril/indapamide/amlodipine vs free combination in uncontrolled hypertension

CTR20181901Phase 3Completed

Sponsor
Servier
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of perindopril + indapamide + amlodipine in essential hypertension, sponsored by Servier. Started Mar 2019; status: completed.

02

Drugs

perindopril + indapamide + amlodipine
03

Conditions

essential hypertension

Beyond the preview

Go deeper on CTR20181901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call